| Literature DB >> 34725555 |
Salima Tiji1, Yahya Rokni2, Ouijdane Benayad1, Nassima Laaraj1, Abdeslam Asehraou2, Mostafa Mimouni1.
Abstract
BACKGROUND: Nigella sativa L. (NS) is an aromatic and medicinal plant commonly used in Mediterranean cuisine. Its grains contain a large amount of fixed oil and have many therapeutic virtues and medicinal properties (antioxidant, antidiabetic, antimicrobial, and anticancer). AIM: The aim of this work is to study the antimicrobial activity of Nigella sativa L. extracts and separated fractions on various pathogenic strains and to correlate that with its chemical composition.Entities:
Year: 2021 PMID: 34725555 PMCID: PMC8557078 DOI: 10.1155/2021/8308050
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1GC chromatogram of esterified hexane extract.
Hexane extract identification by GC-MS.
| Peak | Compound | RT (min) | Area (%) |
|---|---|---|---|
| 1 | Oleic acid | 9.93 | 2.74 |
| 2 | Monoacetate, 1,2,3-propanetriol | 11.31 | 2.40 |
| 3 | Palmitic acid | 22.58 | 30.33 |
| 4 | Linoleic acid | 24.33 | 64.52 |
RT, retention time; area, percentage obtained by electronic integration measurement using a mass detector RT trace. RT, retention time.
Figure 2GC chromatogram of NS essential oil.
NS essential oil characterization by GC-MS.
| Peak | Compound | RT (min) | Concentration |
|---|---|---|---|
| 1 | Alpha-Thujene, origanene, or 3-thujene | 5.00 | 13.60 |
| 2 | Alpha-Pinene | 5.13 | 2.20 |
| 3 | Beta-Pinene | 5.84 | 2.18 |
| 4 | 1,2,4-Trimethylbenzene or pseudocumene, Psi-cumene | 6.10 | 1.30 |
| 5 | Beta-Cymene | 6.60 | 37.76 |
| 6 | Gamma-Terpinene | 7.15 | 0.69 |
| 7 | Lilac aldehyde | 7.79 | 0.55 |
| 8 | 2-Cyclohexen-1-ol, 2-methyl-5-(1-methylethyl)-, (1S-cis) | 8.17 | 2.19 |
| 9 | Thymoquinone | 10.23 | 5.69 |
Fractions of hexane extract identified by GC-MS.
| Fraction | Peak number | Compound | RT (min) | Area (%) |
|---|---|---|---|---|
| (SH1) | 1 | 2.4-Decadienal | 15.11 | 4.95 |
| 2 | Lauric acid | 18.68 | 1.87 | |
| 3 | Palmitic acid | 22.61 | 8.64 | |
| 4 | 17 bromopropanoic acid | 23.26 | 9.3 | |
| 5 | 1-Octadecanol | 23.58 | 17.79 | |
| 6 | Linoleic acid | 24.36 | 18.29 | |
| 7 | Heptadecanoic acid | 24.64 | 11.02 | |
| 8 | 9-Octadecanoic acid (Z), 2-butoxyethyl ester | 25.79 | 28.12 | |
|
| ||||
| (SH2) | 1 | 8-Hydroxyoctanoic acid | 16.23 | 2.61 |
| 2 | Methyl azelaaldehydate | 16.77 | 2.60 | |
| 3 | Azelaic acid | 18.26 | 9.44 | |
| 4 | Laural dimethyl acetal | 18.89 | 12.14 | |
| 5 | Palmitic acid | 22.62 | 40.98 | |
| 6 | Linoleic acid | 24.37 | 17.10 | |
| 7 | 8-Octadecenoic acid | 24.43 | 1.25 | |
| 8 | Heptadecanoic acid | 24.62 | 16.35 | |
|
| ||||
| (SH3) | 1 | 2.4-Decadienal | 15.24 | 1.70 |
| 2 | Palmitic acid, methyl ester | 22.60 | 5.65 | |
| 3 | 1-Octadecanol | 23.84 | 87.32 | |
| 4 | Oleic acid, methyl ester | 24.34 | 5.31 | |
|
| ||||
| (SH4) | 1 | 7,9-Dimethylhexadecane | 15.17 | 9.97 |
| 2 | Hexadecane | 18.13 | 10.84 | |
| 3 | Tricosanoic acid | 22.58 | 11.17 | |
| 4 | 17 pentatriacontene | 24.59 | 60.37 | |
| 5 | Lignocerol | 24.79 | 7.62 | |
|
| ||||
| (SH5) | 1 | 2.6.11.15-Tetramethyl hexadecane | 17.55 | 0.29 |
| 2 | 9-Eicosene (E) | 18.78 | 1.79 | |
| 3 | Palmitic acid, methyl ester | 22.60 | 2.65 | |
| 4 | (Z)-9-tricosene | 23.28 | 2.70 | |
| 5 | Linoleic acid | 24.05 | 92.54 | |
|
| ||||
| (SH6) | 1 | Eicosane | 18.13 | 2.19 |
| 2 | Dichloroacetic acid, heptadecyl ester | 18.77 | 4.08 | |
| 3 | 9-Tricosene | 21.14 | 5.12 | |
| 4 | Palmitic acid, methyl ester | 22.60 | 4.09 | |
| 5 | l-(+)-Ascorbic acid 2.6-dihexadecanoate | 23.03 | 14.37 | |
| 6 | 9-Tricosene | 23.28 | 6.60 | |
| 7 | 1-Octadecanol | 23.91 | 47.22 | |
| 8 | Oleic acid | 24.81 | 12.34 | |
| 9 | 9-Hexacosene | 25.24 | 3.95 | |
|
| ||||
| (SH7) | 1 | 2.3-Dimethylhexadecane | 15.18 | 6.11 |
| 2 | 8-Methylheptadecane | 15.18 | 3.71 | |
| 3 | 2,6,11,15-Tetramethylhexadecan- | 17.55 | 8.44 | |
| 4 | Pentanoic acid, 5-hydroxy-,2,4-di-t-butylphenyl esters | 17.83 | 3.87 | |
| 5 | 2-Methylheptadecane- | 18.13 | 11.68 | |
| 6 | 9-eicosene (E) | 18.78 | 16.82 | |
| 7 | Dichloroacetic acid, heptadecyl ester | 21.15 | 6.42 | |
| 8 | Palmitic acid, methyl ester | 22.60 | 18.89 | |
| 9 | 9-Tricosene. (Z)- | 23.28 | 9.74 | |
| 10 | Linoleic acid | 24.35 | 14.08 | |
|
| ||||
| (SH8) | 1 | 2.4-Decadienal | 15.16 | 3.82 |
| 2 | 9-Eicosene. (E)- | 18.77 | 16.53 | |
| 3 | Dichloroacetic acid, heptadecyl ester | 21.14 | 16.84 | |
| 4 | Palmitic acid, methyl ester | 22.60 | 24.91 | |
| 5 | 1-Octadecanol | 23.58 | 13.23 | |
| 6 | Oleic acid, methyl ester | 24.39 | 5.57 | |
| 7 | Stearic acid, methyl ester | 24.62 | 10.49 | |
| 8 | 9-Hexacosene | 25.23 | 8.59 | |
RT, retention time; area, percentage obtained by electronic integration measurement using a mass detector RT trace.
Acetone extract and its fractions identification by HPLC-DAD.
| Sample | RT (min) | Area (%) | Compound |
|---|---|---|---|
| Extract (FA) | 2.92 | 23.50 | Gallic acid |
| 2.97 | 2.03 | Ascorbic acid | |
| 3.74 | 4.85 | ND | |
| 3.80 | 3.65 | ND | |
| 5.40 | 3.82 | Thymoquinone | |
| 19.22 | 4.95 | Rutin | |
| 22.28 | 8.45 | Naringenin | |
| 27.74 | 8.42 | Quercetin | |
| 32.54 | 2.03 | Kaempferol | |
| 42.42 | 13.20 | Cysteine | |
| 42.50 | 3.73 | ND | |
| 42.60 | 13.27 | Apigenin | |
| 42.73 | 8.05 | ND | |
|
| |||
| Fraction (SA1) | 2.92 | 98.9 | Gallic acid |
|
| |||
| Fraction (SA2) | 2.92 | 25.8 | Gallic acid |
| 5.40 | 12.3 | Thymoquinone | |
| 42.60 | 73.5 | Apigenin | |
|
| |||
| Fraction (SA3) | 2.92 | 5.36 | Gallic acid |
| 39.92 | 79.83 | Catechol | |
|
| |||
| Fraction (SA4) | 22.28 | 88.7 | Naringenin |
|
| |||
| Fraction (SA6) | 3.74 | 10.74 | ND |
| 42.73 | 86.72 | ||
|
| |||
| Fraction (SA7) | 2.97 | 13.9 | Ascorbic acid |
| 42.42 | 82.17 | Cysteine | |
|
| |||
| Fraction (SA8) | 3.80 | 25.21 | ND |
| 42.50 | 72.01 | ||
|
| |||
| Fraction (SA11) | 19.22 | 4.80 | Rutin |
| 27.74 | 7.65 | Quercetin | |
| 42.24 | 12.3 | L-Histidine | |
ND, none determined; RT, retention time; area, percentage obtained by electronic integration measurement using a mass detector RT trace.
Antibacterial activity of hexane ((FH) and (SH (1–9)) and acetone ((FA and SA (1–11)) fractions obtained from N. sativa seeds∗.
| Gram− | Gram+ | |||
| Fractions of hexane extract |
|
|
|
|
|
| ||||
| (FH) | 11 | ND | 12 | 10 |
| (SH1) | 8 | 10 | 11 | ND |
| (SH2) | 8 | ND | 11 | 10 |
| (SH3) | ND | ND | 8 | 10 |
| (SH4) | 15 | ND | 12 | 9 |
| (SH5) | 10 | 9 | ND | ND |
| (SH6) | ND | ND | 12 | 8 |
| (SH7) | ND | ND | 8 | 9 |
| (SH8) | 9 | ND | ND | 11 |
| DMSO (1 mg/mL) | — | — | — | — |
| Tetracycline (1 mg/mL) | 30 | 30 | 30 | 30 |
|
| ||||
| Gram − | Gram+ | |||
| Fractions of acetone extract |
|
|
|
|
|
| ||||
| (FA) | ND | ND | ND | ND |
| (SA1) | ND | ND | ND | ND |
| (SA2) | 10 | ND | ND | 13 |
| (SA3) | 9 | ND | ND | 13 |
| (SA4) | ND | ND | 10 | 9 |
| (SA5) | ND | 9 | 10 | 10 |
| (SA6) | 10 | ND | ND | 9 |
| (SA7) | 10 | 13 | 12 | 11 |
| (SA8) | ND | ND | 12 | 10 |
| (SA10) | ND | ND | 12 | ND |
| (SA11) | ND | ND | ND | ND |
| Tetracycline (1 mg/mL) | 30 | 30 | 30 | 30 |
| DMSO (1 mg/mL) | — | — | — | — |
Values are in mm (inhibition diameter); ND, not detected; DMSO, dimethyl sulfoxide.
Figure 3The biomass growth variation of target bacterial strains in the presence of hexane and acetone fractions.
Determination of essential oil MIC towards antibacterial strains.
| 1000 | 970 | 960 | 950 | 700 | 680 | 500 | Control | |
|---|---|---|---|---|---|---|---|---|
| SA | − | − | − | + | + | + | + | + |
| BC | − | − | − | − | − | − | − | + |
| EC | − | − | − | − | − | + | + |
SA, Staphylococcus aureus; BC, Bacillus cereus; EC, Escherichia coli.
Inhibition diameters (mm) of hexane and acetone fractions obtained against Candida pelliculosa.
| Fractions from hexane extract samples |
|
|
| |
| Hexane extract (FH) | 8 |
| (SH1) | 13 |
| (SH2) | 12 |
| (SH3) | 12 |
| (SH4) | 10 |
| (SH5) | 8 |
| (SH6) | 10 |
| (SH7) | 10 |
| (SH8) | 11 |
| DMSO | ND |
| Cycloheximide 0.01% | 24 |
|
| |
| Fractions from acetone extract samples |
|
|
| |
| Acetone extract (FA) | 18 |
| (SA1) | 10 |
| (SA2) | 11 |
| (SA3) | 12 |
| (SA4) | 10.9 |
| (SA5) | 11 |
| (SA6) | 8 |
| (SA7) | 19 |
| (SA8) | 8 |
| (SA10) | 9 |
| (SA11) | 8 |
| Cycloheximide 0.01% | 24 |
| DMSO | ND |
ND, none determined.
Determination of essential oil MIC towards antifungal strain.
| Concentration ( | 32 | 16 | 8 | 4 | 2 | 1 | Control |
|---|---|---|---|---|---|---|---|
|
| − | − | − | + | + | + | + |